highmark glp-1 coverage Medicaid of and Spending on GLP-1s The evolving landscape of anti-obesity

J Biol Chem 270: 26488-26496, 1995

Avoid entirely

We have access to these because once upon a time, these medications didn't exist

Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation

A study of social media posts showed that around 23 percent of posts about nicotine mentioned a cessation in use in conjunction with GLP-1R agonists

Considere tambin una titulacin ms lenta del medicamento GLP-1 y evite comidas muy grasas que pueden retrasar an ms el vaciamiento gstrico